Catalent, a leading global provider of advanced delivery technologies, development and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, today announced that Steve Hager, PhD, Senior Director, Technical Support will present at the BioProcess International (BPI) East Conference at the Boston Convention and Exhibition Center, Boston, on 9-12 September.

Dr Hager’s presentation, on 10 September at 2:30pm, titled “Beating the Clock: Case Studies in Expediting Biologic Development” during the “Speed from Gene to Market” session will highlight case studies in which project timelines were shortened and the risk was mitigated during biologic development and manufacturing. Catalent Biologics has extensive experience in biopharmaceutical development, undertaking projects resulting in more than 600 monoclonal antibodies and over 80 proteins; and Dr Hager will discuss how strategic partnerships and effective communication can reduce scheduling delays during drug substance development and expedite drug product filling and clinical trial supply timelines.

Dr Hager joined Catalent in 2001, and in his current role, provides technical support for the business development and marketing functions. He has more than 25 years’ experience in the biopharmaceutical industry, a bachelor’s degree in biology from St. Olaf College, Northfield, Minnesota, and a doctorate in physiology and biochemistry from the University of Wisconsin-Madison. Dr Hager also performed his postdoctoral work at the University of Illinois Medical Center.